新一轮药品集中采购价格10省份间对比研究

Comparative Analysis of Medicine Prices in the New Round of Centralized Purchasing from 10 Provinces

目的研究我国10省份新一轮药品集中采购药品中标价格差异,为进一步完善我国各省份药品集中采购工作提供参考。方法基于"2015年全国样本医院药品采购排行榜"和各省份新一轮集中采购目录选择15种药品,通过对比研究法对15种药品的省份间价格、国产药与进口药的价格进行分析,在借鉴世界卫生组织/国际卫生行动组织药品价格标准调查法的基础上,将各省份的药品价格与国际参考价格进行对比分析。结果同种药品在各省份的采购价格不相同,福建省价格明显低于其他省份价格,少数进口药价格明显高于国产药价格,部分药品的中位价格比值超过了合理区间。结论建议各省份参考福建在药品集中采购方面的有益经验,完善各自的集中采购方案;各省份应对国产通过一致性评价的仿制药、进口专利或原研药一视同仁,给予两者公平竞价的机会;将国际参考价格纳入限价参考体系中,制定更加合理的限价标准。

Objective To research the difference of medicines prices in the new round of centralized purchasing from 10 provinces, and provide references for further perfecting centralized medicines procurement of provinces in China. Methods Based on the 2015 national sample hospital medicines procurement ranking list and the new round central- ized procurement of every province, 15 kinds of medicines are selected. By comparative studying, the difference of 15 medicines price among 10 provinces is analyzed. And the difference of prices between the domestic medicines and imported medicines in reference to WHO/HAl drug price standard survey method, the prices of medicines in each province and the international reference prices are analyzed. Results The medicine prices are different in different provinces. The medicines prices of Fujian Province are obviously lower than other provinces. The prices of a few imported medi- cines are obviously higher than those of domestic ones. Median prices ratios of some medicines exceed the reason- able range. Ce^l~i^n It is suggested that every provmce should refer to the useful experience of Fujian Province in medicines centralized procurement, to improve their centralized procurement plans. Every province should grant equal bids for imported patents, domestic generic drugs and original medicines, to make them have consistency bidding. The international reference price is incorporated into the price limit reference system, to make more reasonable price limit standard.